Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

A randomized phase II trial of high-dose chlorambucil vs. fludarabine in patients with advanced B-chronic lymphocytic leukemia. EORTC Leukemia Cooperative Group. (CROSBI ID 92380)

Prilog u časopisu | ostalo

Jakšić, Branimir ; Delmer, Alain A randomized phase II trial of high-dose chlorambucil vs. fludarabine in patients with advanced B-chronic lymphocytic leukemia. EORTC Leukemia Cooperative Group. // Psychological research = Psychologische Forschung, 41 (1999), 3; 127-136-x

Podaci o odgovornosti

Jakšić, Branimir ; Delmer, Alain

engleski

A randomized phase II trial of high-dose chlorambucil vs. fludarabine in patients with advanced B-chronic lymphocytic leukemia. EORTC Leukemia Cooperative Group.

This is EORTC CLL-1 protocol for tratemnt of advanced chronic lymphocytic leukemia comparing high dose chrlorambucil versus fludarabine.

High dose chlorambucil fludarabine CLL

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

41 (3)

1999.

127-136-x

objavljeno

0340-0727

1430-2772

Povezanost rada

Kliničke medicinske znanosti